Site Search
Search Results
Vermont Cancer Advocates Convene at State House to Urge Lawmakers to Expand Access to Biomarker Testing
... in who is benefiting from biomarker testing and biomarker-informed treatment. “Biomarker testing is essential to high-quality, personalized care for many conditions and can be a real gamechanger for many patients, but unfortunately, not everyone who can benefit from biomarker testing is getting it,” said Mike Rollo, ACS CAN Vermont director of government relations. “There are significant disparities in health outcomes for Vermont patients by race, income, and insurance type. Without addressing barriers to care, breakthroughs in personalized treatments could increase these disparities in health outcomes. Already, 20 states have passed similar laws to increase access to comprehensive biomarker testing—and it’s time for Vermont to ...
Expand Access to Biomarker Testing in Vermont
... are working together to make sure more Vermont residents can benefit from this important testing. What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...